Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings
LA JOLLA, Calif., August 30, 2023--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will present new and encore data at the 35th International Epilepsy Congress (IEC) and the American College of Clinical Pharmacology (ACCP) Annual Meeting.
Megane Knight International Epilepsy Congress American College Of Clinical Pharmacology Exchange Commission Longboard Pharmaceuticals Inc Longboard Pharmaceuticals
Source: yahoo.com